Literature DB >> 25869501

Corticotrophin-releasing factor participates in S1PR3-dependent cPLA2 expression and cell motility in vascular smooth muscle cells.

Chao Zhu1, Chunxuan Cao1, Li Dai1, Jie Yuan1, Shengnan Li2.   

Abstract

This work is to investigate the role of CRF receptors in VSMC migration and the relevant mechanisms. We studied the role of CRF receptors in cell motility and found that S1P signaling pathway is involved in the regulation of cPLA2 induced by CRF. S1P is synthesized by Sphk1 and Sphk2 and binds to five GPCR designated S1P1-5. We observed that activation of CRFR1 resulted in increased cell migration, whereas activation of CRFR2 resulted in decreased cell migration. cPLA2 and iPLA2 were knocked down respectively to explore the corresponding effect on cell migration by means of shRNA interference. cPLA2 expression was increased by CRFR1 but decreased by CRFR2. On the contrary, iPLA2 expression was inhibited by CRFR1 but enhanced by CRFR2. The regulation of cPLA2 was in line with the regulation of Sphk1 and hence cell migration after the activation of CRFR1 or CRFR2. Consistently, S1P release was enhanced with CRFR1 activation. Both DMS (Sphk inhibitor) and CAY10444 (S1PR3 inhibitor) attenuated cPLA2 expression and thus decreased cell migration in response to CRF. In addition, CRF could not promote cell migration after S1PR3 silencing. Our results suggest the pro-migratory role of CRFR1-Sphk1-S1P-S1PR3-cPLA2 signaling pathway in VSMCs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRF receptors; Cell motility; S1PR; Sphk1; cPLA2

Mesh:

Substances:

Year:  2015        PMID: 25869501     DOI: 10.1016/j.vph.2015.03.013

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  2 in total

1.  Extracellular Matrix Rigidity-dependent Sphingosine-1-phosphate Secretion Regulates Metastatic Cancer Cell Invasion and Adhesion.

Authors:  Panseon Ko; Daehwan Kim; Eunae You; Jangho Jung; Somi Oh; Jaehyun Kim; Kwang-Ho Lee; Sangmyung Rhee
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

2.  Urocortin suppresses endometrial cancer cell migration via CRFR2 and its system components are differentially modulated by estrogen.

Authors:  Gemma L Owens; Kevin M Lawrence; Tom R Jackson; Emma J Crosbie; Berna S Sayan; Henry C Kitchener; Paul A Townsend
Journal:  Cancer Med       Date:  2017-01-21       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.